Brian T Chan1, Alexander C Tsai. 1. *Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA; †Harvard Medical School, Boston, MA; ‡Center for Global Health and Department of Psychiatry, Massachusetts General Hospital, Boston, MA; and §Mbarara University of Science and Technology, Mbarara, Uganda.
Abstract
BACKGROUND: HIV-related stigma is associated with increased risk-taking behavior, reduced uptake of HIV testing, and decreased adherence to antiretroviral therapy (ART). Although ART scale-up may reduce HIV-related stigma, the extent to which levels of stigma in the general population have changed during the era of ART scale-up in sub-Saharan Africa is unknown. METHODS: Social distance and anticipated stigma were operationalized using standard HIV-related stigma questions contained in the Demographic and Health Surveys and AIDS Indicator Surveys of 31 African countries between 2003 and 2013. We fitted multivariable linear regression models with cluster-correlated robust standard errors and country fixed effects, specifying social distance or anticipated stigma as the dependent variable and year as the primary explanatory variable of interest. RESULTS: We estimated a statistically significant negative association between year and desires for social distance (b = -0.020; P < 0.001; 95% confidence interval: -0.026 to -0.015) but a statistically significant positive association between year and anticipated stigma (b = 0.023; P < 0.001; 95% confidence interval: 0.018 to 0.027). In analyses stratified by HIV prevalence above or below the sample median, declines in social distancing over time were more pronounced among countries with a higher HIV prevalence. CONCLUSIONS: Concomitant with ART scale-up in sub-Saharan Africa, anticipated stigma in the general population increased despite a decrease in social distancing toward people living with HIV. Although ART scale-up may help reduce social distancing toward people living with HIV, particularly in high-prevalence countries, other interventions targeting symbolic or instrumental concerns about HIV may be needed.
BACKGROUND:HIV-related stigma is associated with increased risk-taking behavior, reduced uptake of HIV testing, and decreased adherence to antiretroviral therapy (ART). Although ART scale-up may reduce HIV-related stigma, the extent to which levels of stigma in the general population have changed during the era of ART scale-up in sub-Saharan Africa is unknown. METHODS: Social distance and anticipated stigma were operationalized using standard HIV-related stigma questions contained in the Demographic and Health Surveys and AIDS Indicator Surveys of 31 African countries between 2003 and 2013. We fitted multivariable linear regression models with cluster-correlated robust standard errors and country fixed effects, specifying social distance or anticipated stigma as the dependent variable and year as the primary explanatory variable of interest. RESULTS: We estimated a statistically significant negative association between year and desires for social distance (b = -0.020; P < 0.001; 95% confidence interval: -0.026 to -0.015) but a statistically significant positive association between year and anticipated stigma (b = 0.023; P < 0.001; 95% confidence interval: 0.018 to 0.027). In analyses stratified by HIV prevalence above or below the sample median, declines in social distancing over time were more pronounced among countries with a higher HIV prevalence. CONCLUSIONS: Concomitant with ART scale-up in sub-Saharan Africa, anticipated stigma in the general population increased despite a decrease in social distancing toward people living with HIV. Although ART scale-up may help reduce social distancing toward people living with HIV, particularly in high-prevalence countries, other interventions targeting symbolic or instrumental concerns about HIV may be needed.
Authors: Lucy N Makoae; Carmen J Portillo; Leana R Uys; Priscilla S Dlamini; Minrie Greeff; Maureen Chirwa; Thecla W Kohi; Joanne Naidoo; Joseph Mullan; Dean Wantland; Kevin Durrheim; William L Holzemer Journal: AIDS Care Date: 2009-11
Authors: Abela Mpobela Agnarson; Honorati Masanja; Anna Mia Ekström; Jaran Eriksen; Göran Tomson; Anna Thorson Journal: Trop Med Int Health Date: 2010-07-15 Impact factor: 2.622
Authors: Becky L Genberg; Zdenek Hlavka; Kelika A Konda; Suzanne Maman; Suwat Chariyalertsak; Alfred Chingono; Jessie Mbwambo; Precious Modiba; Heidi Van Rooyen; David D Celentano Journal: Soc Sci Med Date: 2009-05-07 Impact factor: 4.634
Authors: Sae Takada; Viola Nyakato; Akihiro Nishi; A James O'Malley; Bernard Kakuhikire; Jessica M Perkins; David R Bangsberg; Nicholas A Christakis; Alexander C Tsai Journal: Soc Sci Med Date: 2019-05-20 Impact factor: 4.634
Authors: Jennifer Manne-Goehler; Bernard Kakuhikire; Sheilah Abaasabyoona; Till W Bärnighausen; Samson Okello; Alexander C Tsai; Mark J Siedner Journal: AIDS Behav Date: 2019-03
Authors: Daniel E Sack; Caroline De Schacht; Paula Paulo; Erin Graves; Almiro M Emílio; Ariano Matino; Carlota L Fonseca; Arifo U Aboobacar; Sara Van Rompaey; Carolyn M Audet Journal: Glob Health Action Date: 2021-01-01 Impact factor: 2.640